Cargando…

Correction: Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression

Detalles Bibliográficos
Autores principales:	Yu, Junhui, Yang, Kui, Zheng, Jianbao, Zhao, Pengwei, Xia, Jie, Sun, Xuejun, Zhao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918502/ https://www.ncbi.nlm.nih.gov/pubmed/36765033 http://dx.doi.org/10.1038/s41419-023-05662-x

Ejemplares similares

Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression
por: Yu, Junhui, et al.
Publicado: (2022)

Activation of FXR promotes intestinal metaplasia of gastric cells via SHP-dependent upregulation of the expression of CDX2
por: Zhou, Haining, et al.
Publicado: (2018)

Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway
por: Yu, Jun-Hui, et al.
Publicado: (2019)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo
por: Zheng, Jianbao, et al.
Publicado: (2017)

Reconstruction of FXR Beam Conditions
por: Nexsen, W E, et al.
Publicado: (2001)

Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice
por: Saré, Rachel Michelle, et al.
Publicado: (2019)

Structural Studies of the Tandem Tudor Domains of Fragile X Mental Retardation Related Proteins FXR1 and FXR2
por: Adams-Cioaba, Melanie A., et al.
Publicado: (2010)

Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
por: Correia, Jorge C., et al.
Publicado: (2015)

FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion
por: Fan, Yichao, et al.
Publicado: (2017)

CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression
por: Yu, Junhui, et al.
Publicado: (2019)

FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection
por: Li, Zhe, et al.
Publicado: (2023)

The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma
por: Di Matteo, S., et al.
Publicado: (2019)

Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
por: Yu, Junhui, et al.
Publicado: (2020)

SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
por: Cui, Shuang, et al.
Publicado: (2023)

FXR controls CHOP expression in steatohepatitis
por: Fuchs, Claudia D., et al.
Publicado: (2017)

FXR expression in rats of hilar cholangiocarcinoma
por: Zhang, Meng-yu, et al.
Publicado: (2022)

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
por: Brevini, Teresa, et al.
Publicado: (2022)

FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model
por: Deuschle, Ulrich, et al.
Publicado: (2012)

Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis
por: Nijmeijer, Rian M., et al.
Publicado: (2014)

Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand
por: Li, Jiang, et al.
Publicado: (2010)

BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
por: Jung, Hyunkyung, et al.
Publicado: (2020)

CDX2 inhibits epithelial–mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression
por: Yu, Junhui, et al.
Publicado: (2020)

Natural Product 2-Oxokolavenol Is a Novel FXR Agonist
por: Guo, Fusheng, et al.
Publicado: (2022)

FXR induces SOCS3 and suppresses hepatocellular carcinoma
por: Guo, Fei, et al.
Publicado: (2015)

Chlorogenic Acid Inhibits Lipid Deposition by Regulating the Enterohepatic FXR-FGF15 Pathway
por: Ye, Xiaolin, et al.
Publicado: (2022)

Transcriptional regulation of autophagy by an FXR/CREB axis
por: Seok, Sunmi, et al.
Publicado: (2014)

FXR an emerging therapeutic target for the treatment of atherosclerosis
por: Mencarelli, Andrea, et al.
Publicado: (2010)

Fatty liver diseases, bile acids, and FXR
por: Zhu, Yan, et al.
Publicado: (2016)

Update on FXR Biology: Promising Therapeutic Target?
por: Han, Chang Yeob
Publicado: (2018)

Fxr1 regulates sleep and synaptic homeostasis
por: Khlghatyan, Jivan, et al.
Publicado: (2020)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Role of FXR in Renal Physiology and Kidney Diseases
por: Guo, Yanlin, et al.
Publicado: (2023)

FXR and NASH: an avenue for tissue-specific regulation
por: Henry, Zakiyah, et al.
Publicado: (2023)

FXR Friend-ChIPs in the Enterohepatic System
por: Meadows, Vik, et al.
Publicado: (2023)

Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions
por: Zaufel, Alex, et al.
Publicado: (2021)

Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection
por: Prayitno, Khairunnadiya, et al.
Publicado: (2023)

Transcription Factor FXR Activates DHRS9 to Inhibit the Cell Oxidative Phosphorylation and Suppress Colon Cancer Progression
por: Zhao, Jinlai, et al.
Publicado: (2022)

FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity
por: Wu, Kun, et al.
Publicado: (2020)

Deciphering the nuclear bile acid receptor FXR paradigm
por: Modica, Salvatore, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3r6gkqgk71vla4rd989p26anc4